Chiesi Farmaceutici S.p.A.
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Renal & urogenital · Respiratory · Women's health
Chiesi Farmaceutici S.p.A. is a clinical trial sponsor. It has 22 active clinical trials with 29,467 planned participants, across 12 therapeutic areas. Since 2021 it has completed 76 trials and stopped 14 early.
Trial track record · since 2021
Pipeline · 22 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Chiesi Farmaceutici S.p.A
Chiesi Farmaceutici S.p.A is lead sponsor of 22 active clinical trials on ClinicalTrials.gov, with 29,467 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 76 trials and stopped 14 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Chiesi Farmaceutici S.p.A; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Chiesi Farmaceutici S.p.A..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.